Retirement Planning CO Of New England, Inc. Gilead Sciences, Inc. Transaction History
Retirement Planning CO Of New England, Inc.
- $199 Million
- Q4 2024
A detailed history of Retirement Planning CO Of New England, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Retirement Planning CO Of New England, Inc. holds 11,144 shares of GILD stock, worth $1.16 Million. This represents 0.52% of its overall portfolio holdings.
Number of Shares
11,144
Previous 11,045
0.9%
Holding current value
$1.16 Million
Previous $925,000
11.24%
% of portfolio
0.52%
Previous 0.47%
Shares
13 transactions
Others Institutions Holding GILD
# of Institutions
2,072Shares Held
1.02BCall Options Held
9.63MPut Options Held
10.2M-
Black Rock Inc. New York, NY121MShares$12.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.46 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.28 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.03 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $130B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...